This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Crucian, B. Articles by Widen, R. Search for Related Content PubMed PubMed Citation Articles by Crucian, B. Articles by Widen, R.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, 07 1996, 411-416, Vol 3, No. 4
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Detection of altered T helper 1 and T helper 2 cytokine production by peripheral blood mononuclear cells in patients with multiple sclerosis utilizing intracellular cytokine detection by flow cytometry and surface marker analysis

B Crucian, P Dunne, H Friedman, R Ragsdale, S Pross and R Widen
Department of Medical Microbiology and Immunology, College of Medicine, University of South Florida, Tampa 33612, USA.

Production of T helper 1 and T helper 2 cytokines was investigated in peripheral blood mononuclear cells (PBMCs) from multiple sclerosis (MS) patients by a newly described technique, detection of intracellular cytokines by flow cytometry in conjunction with immunophenotype analysis. T-cell gamma interferon (IFN-gamma) production and interleukin 10 (IL-10) production were examined after PBMC activation with T-cell mitogens at 5 and 24 h, and monocyte spontaneous production of IL-10 and production after PBMC activation with lipopolysaccharide (LPS) for 24 h were also examined. The data indicate that MS patients have decreased percentages of T cells capable of secreting IFN-gama compared with healthy controls, and this change is detectable at 5 and 24 h. the patients displaying decreased T-cell production of IFN-gamma were essentially confined to a group being treated with the newly approved drug Betaseron (berlex Labs, Cedar Knolls, N.J.), a recombinant form of IFN-beta (rIFN-beta 1b). By gating of the entire lymphocyte population, analysis of IFN-gama production in T cells (CD3+ versus that in non-T cells (CD3+) was possible. The percentage of IFN- gamma-producing lymphocytes that was made up of T cells was essentially unchanged between the Betaseron-treated patients, non-Betaseron-treated patients, and controls, indicating that the suppression of IFN-gamma production displayed by betaseron-treated MS patients was a nonspecific suppression of all IFN-gamma-producing lymphocytes as opposed to a suppression of T-cell production only. The data seem to indicate that treatment of MS with Betaseron corresponds to an inhibition of the lymphocyte's ability to produce IFN-gamma. No changes were detected in T-cell production of IL-10 at either time point. We also observed that MS patients in general appear to have small percentages of peripheral blood monocytes spontaneously producing slight but detectable levels of IL-10. No difference was seen regarding monocyte production of IL-10 after PBMC activation with LPS between MS patients and controls. Both populations responded with high percentages of monocytes producing IL- 10. The data seem to indicate that treatment of MS with Betaseron, known to decrease the exacerbation rate of relapsing-remitting MS, corresponds to a suppression of peripheral blood lymphocyte production of IFN-gamma. Monocyte production of IL-10 may also play a role in regulating the disease process.

This article has been cited by other articles:

• Walker, D., Jason, J., Wallace, K., Slaughter, J., Whatley, V., Han, A., Nwanyanwu, O. C., Kazembe, P. N., Dobbie, H., Archibald, L., Jarvis, W. R. (2002). Spontaneous Cytokine Production and Its Effect on Induced Production. CVI 9: 1049-1056 [Abstract] [Full Text]  
• O'Neil-Andersen, N. J., Lawrence, D. A. (2002). Differential Modulation of Surface and Intracellular Protein Expression by T Cells after Stimulation in the Presence of Monensin or Brefeldin A. CVI 9: 243-250 [Abstract] [Full Text]  
• Glaser, R., MacCallum, R. C., Laskowski, B. F., Malarkey, W. B., Sheridan, J. F., Kiecolt-Glaser, J. K. (2001). Evidence for a Shift in the Th-1 to Th-2 Cytokine Response Associated With Chronic Stress and Aging. J. Gerontol. A Biol. Sci. Med. Sci. 56: M477-482 [Abstract] [Full Text]  
• Frassanito, M. A., Cusmai, A., Iodice, G., Dammacco, F. (2001). Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis. Blood 97: 483-489 [Abstract] [Full Text]  
• Berguer, R., Bravo, N., Bowyer, M., Egan, C., Knolmayer, T., Ferrick, D. (1999). Major Surgery Suppresses Maximal Production of Helper T-Cell Type 1 Cytokines Without Potentiating the Release of Helper T-Cell Type 2 Cytokines. Arch Surg 134: 540-544 [Abstract] [Full Text]  
• Bongioanni, P., Mosti, S., Moscato, G., Lombardo, F., Manildo, C., Meucci, G. (1999). Decreases in T-Cell Tumor Necrosis Factor {alpha} Binding With Interferon Beta Treatment in Patients With Multiple Sclerosis. Arch Neurol 56: 71-78 [Abstract] [Full Text]